Article
Allele-specific HLA LOH in solid tumors: distinct patterns by tumor type and potential prognostic relevance.
Journal for immunotherapy of cancer - 9 Sept 2025
Sewastianik Tomasz, Roy Christian, Gormally Michael V, Montesion Meagan, Halvey Patrick, Jindal Aastha, Lam Hubert, Schoenfeld Adam, Klebanoff Christopher A, Opiteck Gregory J, Nagorsen Dirk
Abstract excerpt
T-cell receptors (TCRs) recognize antigens derived from fragments of somatically expressed proteins that are degraded by the proteasome and presented by specific human leukocyte antigen (HLA) molecules. Recent therapeutic advances using the TCR as a tumor-targeting moiety have focused attention on HLA loss of heterozygosity (LOH) as a potential resistance mechanism. Allele-specific LOH, rather than...
Topics
- Humans
- Loss of Heterozygosity
- Prognosis
- Alleles
- Neoplasms
- HLA Antigens
- Female
- Male
